Specifically, EBV(+) DLBCL demonstrated a significant predominance of CD8(+) T-cells (p = 0.01), with a relative predominance of monocytes (p = 0.11), neutrophils (p = 0.08), and NK cells (p = 0.11). Here, CD8A is linked to diffuse large B-cell lymphoma.